Hepatotoxicity and antioxidant activity of some new N,N′-disubstituted benzimidazole-2-thiones, radical scavenging mechanism and structureactivity relationship

被引:31
作者
Anastassova, Neda O. [1 ]
Mavrova, Anelia Ts. [1 ]
Yancheva, Denitsa Y. [2 ]
Kondeva-Burdina, Magdalena S. [3 ]
Tzankova, Virginia I. [3 ]
Stoyanov, Simeon S. [2 ]
Shivachev, Boris L. [4 ]
Nikolova, Rositsa P. [4 ]
机构
[1] Univ Chem Technol & Met, 8 Kliment Ohridski Blvd, BU-1756 Sofia, Bulgaria
[2] Bulgarian Acad Sci, Inst Organ Chem, Ctr Phytochem, Acad G Bonchev Str,Bldg 9, BU-1113 Sofia, Bulgaria
[3] Med Univ Sofia, Fac Pharm, Drug Metab & Drug Tox Lab, Pharmacol Pharmacotherapy & Toxicol Dept, Sofia, Bulgaria
[4] Bulgarian Acad Sci, Acad Ivan Kostov Inst Mineral & Crystallog, Acad G Bonchev Str,Bldg 107, BU-1113 Sofia, Bulgaria
关键词
1,3-Disubstituted benzimidazole-2-thiones; Michael addition; Hepatotoxicity; Oxidative stress; Radical scavenging; DFT calculations; OXIDATIVE STRESS; LIPID-PEROXIDATION; INTERMOLECULAR INTERACTIONS; ANTIVIRAL ACTIVITY; DERIVATIVES; MELATONIN; INHIBITORS; ANALOGS; DAMAGE;
D O I
10.1016/j.arabjc.2016.12.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new method for the synthesis of 1,3-disubstituted benzimidazole derivatives was developed using aza-Michael addition. The target compounds were synthesized in good yields and purity and tested on isolated hepatocytes for their toxicity and antioxidant activity. The antioxidant properties of the substances with lowest toxicity were evaluated using oxidative stress induced by tertbutyl hydroperoxide (tert-BOOH). Some of them as methyl 3-[ 3-(3-methoxy-3-oxopropyl)-5-ben zoyl-2-thioxo-2,3-dihydro-1H-benzimidazol-1-yl] propanoate 10 and 1,3-bis[ 3-(hydrazinooxy)-3-oxo propyl]-5-benzoyl-1,3-dihydro-2H-benzimidazole-2-thione 15 exhibited statistically significant cytoprotective and antioxidant effects which were similar to those of quercetin. In order to estimate the influence of the structure on the biological properties, structural characterization of the studied compounds was performed by X-ray diffraction analysis and DFT methods. On the basis of the calculated reaction enthalpies of hydrogen atom abstraction (HAT mechanism) and single-electron transfer (SET mechanism) the mechanisms of the antioxidant action of the tested compounds were studied. Subsequently it was established that the HAT mechanism governs the radical scavenging of 10 and 15 in the lipid phase, while the SET mechanism is preferred in water medium for 10 and competitive to HAT for 15. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under theCCBY-NC-NDlicense.
引用
收藏
页码:353 / 369
页数:17
相关论文
共 83 条
  • [21] Fau D, 1994, J PHARMACOL EXP THER, V269, P1
  • [22] Frankel E.N., 1998, Lipid oxidation
  • [23] Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents
    Gaba, Monika
    Singh, Sarbjot
    Mohan, Chander
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 76 : 494 - 505
  • [24] Galano A., 2001, PHYS CHEM CHEM PHYS, V13, P7147
  • [25] Melatonin as a natural ally against oxidative stress: a physicochemical examination
    Galano, Annia
    Tan, Dun Xian
    Reiter, Russel J.
    [J]. JOURNAL OF PINEAL RESEARCH, 2011, 51 (01) : 1 - 16
  • [26] Electrodonating and electroaccepting powers
    Gazquez, Jose L.
    Cedillo, Andres
    Vela, Alberto
    [J]. JOURNAL OF PHYSICAL CHEMISTRY A, 2007, 111 (10) : 1966 - 1970
  • [27] Grimmet M., 1997, SYNTHESIS SPECIFICAL, P227
  • [28] Synthesis and evaluation of in vitro antioxidant capacities of some benzimidazole derivatives
    Gurer-Orhan, Hande
    Orhan, Hilmi
    Suzen, Sibel
    Puskullu, M. Orhan
    Buyukbingol, Erdem
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2006, 21 (02) : 241 - 247
  • [29] The palladium complexes of a C3-bridged di(benzimidazol-2-ylidene) ligand via cleavage of a dibenzotetraazafulvalene
    Hahn, FE
    von Fehren, T
    Lügger, T
    [J]. INORGANICA CHIMICA ACTA, 2005, 358 (14) : 4137 - 4144
  • [30] Oxidative stress and neurodegeneration: where are we now?
    Halliwell, Barry
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 97 (06) : 1634 - 1658